PPARGC1A and liver cancer: The synergistic cytotoxic effects of NAR and ferroptosis inducers were reversed when the cells were pretreated with AMPK inhibitors or PGC1α inhibitors, confirming that the inhibition of aerobic glycolysis mediated through the AMPK-PGC1α signaling pathway is crucial for NAR reducing liver cancer resistance to ferroptosis (82).